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Available online 29 February 2008Damaging environment, certain intracellular defects or heterologous expression of pro-apoptotic genes
induce death in yeast cells exhibiting typical markers of apoptosis. In mammals, apoptosis can be directed by
the activation of groups of proteases, called caspases, that cleave speciﬁc substrates and trigger cell death. In
addition, in plants, fungi, Dictyostelium and metazoa, paracaspases and metacaspases have been identiﬁed
that share some homologies with caspases but showing different substrate speciﬁcity. In the yeast
Saccharomyces cerevisiae, a gene (MCA1/YCA1) has been identiﬁed coding for a metacaspase involved in the
induction of cell death. Metacaspases are not biochemical, but sequence and functional homologes of
caspases, as deletion of them rescues entirely different death scenarios. In this review wewill summarize the
current knowledge in S. cerevisiae on apoptotic processes, induced by internal and external triggers, which are
dependent on the metacaspase gene YCA1.




Apoptosis or programmed cell death (PCD) is a highly coordinated
cellular suicide program that is crucial for maintenance of health and
tissue function and alterations of this process can lead to cancer or
neurodegenerative disorders.
Cells can undergo awide variety of ways to die and the deﬁnition of
“apoptosis” is very arduous. Recently, the Nomenclature Committee
on Cell Death (NCCD) suggested some guidelines for the deﬁnition of
the numerous cell death processes and recommended that the term
apoptosis should be used only for particular morphological changes
during cell death [1]. These changes are: rounding-up of the cell,
retraction of pseudopodes, reduction of the cellular volume (pykno-
sis), condensation of the chromatin, fragmentation of the nucleus
(karyorhexis), little or no ultrastructural modiﬁcation of cytoplasmic
organelles, plasma membrane blebbing and maintenance of an intact
plasma membrane until late stages of the process. In the deﬁnition of
apoptosis, the NCCD also mentioned that it is possible to use the terms
‘apoptosis associated with caspase activation’ and ‘apoptosis without
evidence of caspase activation’.
Due to the complexity of the phenomenon, many and sometimes
contradictory results for the regulation of apoptosis have been re-
ported by different groups, depending on tissue, organism, and experi-
mental conditions used. Some of the regulatory networks were
discovered by the use of model organisms Drosophila melanogaster
and Caenorhabditis elegans, and at present it is accepted the notion that
apoptosis also occurs in Saccharomyces cerevisiae.9 6 49912256.
zzoni).
l rights reserved.Although in the yeast genome there are no genes similar to those of
the mammalian Bax and Bcl family, it was shown that Bax-mediated
cell death in S. cerevisiae is accompanied by typical features of apo-
ptosis, such as externalization of phosphatidylserine at the surface of
the cytoplasmic membrane, cytochrome c release, membrane bleb-
bing, chromatin condensation andmargination and DNA cleavage. The
simultaneous expression of Bcl-xL prevents these effects and cell
death [2].
Several other studies revealed that certain mutations in the S.
cerevisiae genome induce cell death accompanied by the appearance
of features of the mammalian apoptotic cells [3].
In the opposite direction, some genes involved in yeast cell death
have been conﬁrmed as apoptotic regulators in metazoans.
Yeast analogues of somecrucial components of the apoptotic cascade
in mammals have also been described, i.e., caspase (see below) [4],
Omi [5], AIF [6] and EndoG [7] suggesting that the basic machinery of
apoptosis is indeed present and functional also in unicellular organisms.
2. Caspase and metacaspase
The caspases are members of a family, or structurally related
group, known as cysteine proteases.
The name caspase derives from cysteine-dependent aspartate
speciﬁc protease: catalysis is driven by a critical conserved cysteine
side chain of the enzyme, and by a stringent speciﬁcity for cleaving
protein substrates containing aspartic acid. The use of a Cys side chain
as a nucleophile during peptide bond hydrolysis is common to several
protease families [8], but the primary speciﬁcity for aspartate is very
rare among proteases.
The activation of caspases has been recognized as one of the key
processes linked to apoptosis in mammalian cells in which several
caspases, grouped into two classes, have been described. A cell death
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(caspase 8, 9, 10 and 12) that, in turn, activate a second group of
caspase, called effector caspases (caspase 3, 6 and 7) that, ﬁnally, cut
substrates crucial for cell death [9–11]. Mammalian caspases speciﬁ-
cally cut substrates after an aspartic acid (Asp) residue located in the P1
position of the X-Glu-X-Asp consensus sequence,where X is any amino
acid [11]. The occurrence of this sequence is relatively commonwithin
proteins but only few of them will be bona ﬁde caspases substrates in
vivo. In fact, to be a real caspase substrate, other important criteria have
to be fulﬁlled such as the nature of the ﬁrst residue at the P1′ position
located immediately after the scissile bond (charged or bulky residues
are poorly tolerated), and the position of the cleavage site in highly
ﬂexible and exposed linkers that are more accessible to caspases [8].
The analysis of the S. cerevisiae genome did not reveal the presence
of caspases, but by sequence comparison ORF YOR197wwas identiﬁed
coding for a caspase-like protein, ﬁtting into the type I category of
metacaspases, and it was named MCA1 [12,13].
Recent studies demonstrated that, following an apoptotic stimulus,
the product of MCA1 was processed by the proteolytic removal of a
14 kDa peptide leading, as in mammalian caspases, to the activation of
the metacaspase. Moreover, it has been demonstrated that the
conserved Cys297 residue is necessary for the proteolytic cleavage
and is important for the fully activity of the caspase [4].
Lysates fromyeast over-expressing theMCA1 gene could efﬁciently
cleave IETD-AMC peptide, a caspase substrates typical of initiator
caspases (i.e. caspase 8), while no activity was found toward DEVD-
AMC, a characteristic substrate for effector caspases (i.e. caspase 3)
suggesting that MCA1 could operate as the initiator caspase 8. The
over-expression ofMCA1 rendered cells more susceptible to cell death
following an apoptotic stimulus, being cell death completely abolished
in the presence of the caspase inhibitor zVAD-fmk. Conversely, yeast
mutants lacking the MCA1 gene survived to hydrogen peroxide
treatment and to aging better than wild type cells [4].
From these results, Yor197w was proposed as a bona ﬁde caspase
gene in S. cerevisiae and it was renamed YCA1 (Yeast CAspase) [4].
The apoptotic events observed in S. cerevisiae, due to external
stimuli as well as internal signals, were often dependent on the
activity of the yeast metacaspase Yca1p while, in other cases, cell
death occurred also in the absence of this activity. In this review we
will summarize the current knowledge on apoptosis in the yeast S.
cerevisiae dependent on the metacaspase gene YCA1.
3. The intrinsic apoptotic pathway and the role of mitochondria
In mammals, the extrinsic and intrinsic pathways are the main
routes leading to caspase-dependent apoptosis.
The intrinsic pathway is characterized bymitochondrial outer mem-
brane permeabilization (MOMP) that is a crucial step in the intrinsic
apoptotic pathway in mammalian cells. Organelle swelling and rupture
of the mitochondrial outer membrane is caused by the opening of a
mitochondrial pore, thepermeability transitionpore (PTP),whosemajor
components identiﬁed so far and conserved in eukaryotes, are the
adenine nucleotide transporter (ANT), the voltage-dependent anion
channel (VDAC) and cyclophilin D [14–16]. Permeabilization of the outer
mitochondrial membrane is followed by the release from themitochon-
drial inter-membrane space of many proteins, among which are
cytochrome c, Smac/DIABLO, OMI/HtrA2, Apoptosis Inducing Factor
(AIF) and endonuclease G, that trigger the apoptotic cascade.
Released cytochrome c, in the presence of ATP (dATP), binds to
Apaf1 triggering its oligomerization that is followed by pro-caspase-9
recruitment and autoactivation. The resulting complex is called
“apoptosome”.
The yeast genome codes for many proteins of the basic molecular
machineryexecuting cell death, including components of PTP, caspases
[4], AIF [6], HtrA2/Omi [5], and inhibitor of apoptosis (IAP) proteins
[17],while others components seem to be absent (Apaf1, Smac/Diablo).The release of cytochrome c in yeast was ﬁrstly demonstrated in
cells expressing the human pro-apoptotic protein Bax [18]. Upon Bax
expression, a decrease of cytochrome c oxidase and a dramatic
increase in the release of cytochrome c to the cytosol were observed,
while other components of the inner mitochondrial membrane (bc1
complex and F0F1-ATPase) were unaffected.
The requirement of cytochrome c in caspase activation is well
documented inmammals. Inmice, inwhich the cytochrome c gene has
been deleted, the caspase-9–Apaf1 pathway is severely impaired [19].
Similarly, the deletion of the yeast genes encoding the two iso-
forms of cytochrome c does not abolish death but delays the cellular
responses to several death stimuli [20–23].
It has been reported that functional cytochrome c–GFP fusion,which
was not released to cytosol, still induced cell death [24], suggesting that
other pathways might be involved in triggering apoptosis in yeast.
The role of AAC1/2/3 and POR1, the yeast orthologues of
mammalian ANT and VDAC, respectively, in the release of cytochrome
c in Bax induced cell death is controversial in that contradictory results
were obtained depending on growth and Bax induction conditions
[20,25–28].
Recent studies analyzed the involvement of AAC1/2/3 and POR1 in
yeast cell death after treatment with acetic acid, hydrogen peroxide
and diamide that are known to be yeast apoptosis inducers. All this
triggers enhance apoptosis in POR1 deletion mutants suggesting that
Por1p, inwild type cells,mayoppose to apoptosis. In contrast, the same
triggers have no effect in mutants lacking CPR3, the gene encoding the
yeastmitochondrial cyclophilin [29]. It has been reported that, inmice,
Cyclophilin D is involved in necrotic rather than apoptotic cell death
[30].
The absence of ADP/ATP carrier (AAC) proteins, encoded by AAC1/
2/3, protected cells exposed to acetic acid and diamide but not to
hydrogen peroxide. Moreover, after acetic acid treatment, cytochrome
c was not signiﬁcantly released to the cytosolic fraction and was
apparently degraded within mitochondria [29].
The increased sensitivity of the aac1/2/3 mutant to hydrogen
peroxide is an unexpected result. Anyway, it has been reported that
mitochondrial respiration mutants show high sensitivity to H2O2,
probably due to the production of superoxide and reactive hydroxyl
radicals following the impairment of the electron transport chain [31].
The contemporary presence of H2O2 and hydroxyl radicals might
overcome the protective effect of the absence of the AAC proteins [29].
Over-expression of YCA1 in the aac1/2/3mutant did not increase cell
death conﬁrming that, as inmammals, the release of cytochrome c from
mitochondria is necessary for caspase activation in response to H2O2 [7].
The involvement of cytochrome c in metacaspase activation has
also been suggested after exposing yeast cells to hyperosmotic stress
[23].
Cells missing AAC still exhibited apoptotic markers after exposure
to acetic acid and hydrogen peroxide, suggesting again that yeast
cells posses other death pathways that are not linked to MOMP and
cytochrome c release.
Such pathways exist in mammals and involve EndoG and AIF1, two
nucleases that relocate frommitochondria to the nucleus following an
apoptotic stimulus [32,33]. The genes encoding these proteins have
orthologs in yeast, namely NUC1 (YJL208c) and YNR074c, respectively,
which might account for cytochrome c and caspase-independent
apoptotic pathway [6,7].
The contribution of mitochondria metabolism and biogenesis to
yeast apoptosis is still controversial and it has been recently reviewed
[34].
Actually, in some cases the elimination of mitochondrial DNA (ρ0
derivative strains) rescue cell viability, suggesting that mitochondria
are important to mediate cell death response.
Mitochondria exist in the cell as a tubular network that undergoes
ﬁssion and fusion constantly. The equilibrium between fusion and
ﬁssion is fundamental and the fragmentation of tubular mitochondria
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mammalian cells [35].
The machinery responsible for mitochondrial ﬁssion in healthy
yeast cells was identiﬁed in yeast as a complex of three proteins,
Dnm1, Mdv1/Net2, and Fis1 [36]. Deletion of any one of these three
genes causes yeast mitochondria to become fused into a large network
that has been shown to regulate programmed cell death [37]. Cell
death induced by deletion of the mitochondrial ﬁssion factor FIS1 is
abrogated by additional deletion of YCA1 [37].
Similar results were observed in yeast mutants lacking the major
mitochondrial citrate synthase (CS) Cit1p [38]. In this case, it was also
demonstrated that the deletion of YCA1 prevented heat sensitivity as
well as the premature aging of the cit1 mutants.
Recently, it has been reported the involvement in apoptosis of ISC1,
the gene encoding the inositolphosphosphingolipid phospholipase
C. Isc1p, that translocates to mitochondria in the post-diauxic phase,
plays an important role in the regulation of cellular redox homeostasis
through modulation of iron levels. Isc1p deﬁciency results in oxidative
stress hypersensitivity associated with apoptotic markers that were
suppressedby thecontemporaryabsenceof theYca1pmetacaspase [39].
4. Apoptosis under physiological conditions
Among the physiological conditions that can induce programmed
cell death in yeast there are: i) the presence of small quantities of the
conjugation pheromone (mating type pheromone), ii) the develop-
ment of colonies on solid media, iii) the chronological aging, and iv)
the killer toxin [40–44].
The involvement of YCA1 in triggering cell death has been demon-
strated only for the two latter cases.
Chronological life span is measured on yeast populations that have
reached saturation after utilizing the nutrients present in the incu-
bation medium. Chronologically aged yeast cultures die exhibiting
typical markers of apoptosis. Disruption of the apoptoticmachinery by
deletion of YCA1 increases the survival in long term cultures but it is
disadvantageous for the population as, in direct competition assays,
the wild type cells outlast the disruptants [41]. An aged yca1-null
mutant strain is no longer able to regrow when nutrients become
available after a period of starvation, leading to a population with a
high percentage of damaged and old cells. This indicates a physiolo-
gical role of apoptosis in yeast essential to operate a selection for the
ﬁtter cells in aging-related cell death.
The killer phenotype, ﬁrstly described in S. cerevisiae, is a wide-
spread phenomenon among a great variety of yeast genera. Killing is
typically associated to the secretion of a lowmolecularmass protein or
glycoprotein toxin (killer toxin) that kills sensitive cells, of the same or
related yeast genera, without direct cell–cell contact in a two-step
receptor-mediated process.
In S. cerevisiae, three different killer toxins (K1, K2, and K28) have
been identiﬁed so far all encoded as precursor of the secreted alpha/
beta toxins by cytoplasmic double-stranded RNA viruses [45].
In low concentrations, all three virally encoded yeast toxins induce
apoptotic cell death accompanied by apoptotic markers. The yeast
caspase Yca1p and the generation of ROS mediate this process. In
contrast, high concentrations of killer toxins induce non-apoptotic
necrotic cell death, which is independent of Yca1p and ROS [42,43]. It
can be concluded that in natural environment, where the toxin
concentration is usually low, killer yeast can eliminate competitor
sensitive yeasts through the induction of apoptosis.
5. Involvement of YCA1 in apoptosis induced by external stimuli
5.1. Hydrogen peroxide
A broad range of stress conditions and drugs induce the apoptotic
program of S. cerevisiae, low doses of H2O2 and acetic acid being themost popular triggers [46,47]. Strains deleted in the YCA1 gene can
survive better than wild type to H2O2 and, conversely, the over-
expression of YCA1 enhances cell death and exhibition of apoptotic
markers, resulting in premature cell death [4].
5.2. Acetic acid
It has been reported that the presence of Yca1p is crucial for acetic
acid-programmed cell death (AA-PCD) [4] but, in this case, the YCA1
genemight play amore complicated role. In fact, in another study, only
20–30% of caspase-positive cells were detected by ﬂow cytometry in
the population undergoing apoptosis induced by 400 mM acetic acid,
suggesting that yeast caspase seems less relevant in this apoptotic
pathway compared to other apoptotic stimuli like H2O2 induced oxi-
dative stress [48].
It has been proposed that YCA1 participates in AA-PCD in a manner
unrelated to its caspase activity although, at the moment, the
explanation of the reduced rate of cell death in yeast strains lacking
YCA1 can be only speculative [49].
5.3. Hyperosmotic stress
It has been recognized that, in mammalian cells, hyperosmotic
stress induces apoptosis and is involved in several pathological states
such as ischemia, septic shock and diabetic coma [50,51].
The role of YCA1 in PCD induced by hyperosmotic stress seems to
be quite evident. Yeast cells exposed to 60% glucose (w/w) or 60%
sorbitol (w/w) or 0.7–1.2 M NaCl showed apoptotic cell death and
caspase activation [23,52]. In YCA1 disruptants, viability was increased
compared to the wild type, but a slight metacaspase activity was still
detected after osmotic stress, suggesting the existence of unknown
additional activities.
During osmotic stress Yca1p activation depends on the presence of
theYca1p-interactor Sro77p (see also below), in that the caspase activity
in mutants lacking SRO77 was similar to that of cells deleted in YCA1.
In contrast, Sro7p, the Sro77p homolog, has a negative effect on the
Yca1p activation. In fact, the caspase activity was higher in the salt-
sensitive sro7 mutant compared to the wild type.
Anyway, the observation that sro77/yca1 and sro7/sro77/yca1 mu-
tants still showed diagnostic hallmarks of apoptosis, suggests the
existence of an Yca1p-independent apoptotic pathway in yeast.
5.4. Valproic acid
An even more striking effect of the YCA1 deletion was observed in
cells treated with valproic acid (VPA), a short-chained fatty acid
widely used as an anticonvulsant and showing teratogenic and anti-
tumor properties [53].
VPA is also known to induce apoptosis inmammalian cells and it has
been recently identiﬁed as an inhibitor of a class of histone deacetylases
[54–56].
Yeast yca1 mutant cells retained 90% of viability after treatment
with 25 mM valproic acid, a concentration that completely killed wild
type cells [57]. Increasing the VPA concentration up to 50 mM, rather
autophagic cell death was induced that was no more dependent on
YCA1.
5.5. Arsenic
Arsenic is a toxic metalloid with a long history of usage as a
therapeutic agent. An important mechanism of this ancient remedy is
its pro-apoptotic effects onmammalianmalignant cells. Arsenic is also
able to trigger S. cerevisiae cell death through a process associated
with classical apoptotic markers. After arsenic treatment, the sur-
vival of the YCA1-disrupted strain was higher (91.3%) compared to
the wild type strain (50.3%). Furthermore, the occurrence of DNA
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the mutant (1.5%) compared to the wild type (34.3%) [58].
5.6. Caffeine
Caffeine is also known to induce apoptosis in mammalian cells
and this event is mediated by the p53, Bax and caspase 3 pathways
[59].
In yeast, caffeine is known to affect the protein kinase C (PKC)–
mitogen-activated protein kinase (MAPK) pathway. Although there
are no experimental evidences directly linking caffeine treatment to
the induction of apoptosis, it has been demonstrated that caffeine
sensitivity of a pro-apoptotic mutant (Kllsm4Δ1) was fully suppressed
by the contemporary inactivation of YCA1, suggesting that this com-
pound could trigger cell death through a caspase-dependent pathway
[60].
5.7. Metal ions
Transition metals, as an important part of trace nutritional ele-
ments, are essential to life because of the catalytic and structural roles
they play inside or outside cells. Nevertheless, excessive amounts of
metal ions can also be toxic to the cell. For example, exposure to high
levels of manganese (Mn), an element found in several important
enzymes within diverse locations in the cell, including the Golgi,
mitochondria and cytoplasm, can lead to manganism, a Parkinson's
disease-like neurological disorder with characteristic syndromes of
mental difﬁculties and impairments in motor skills [61,62]. It has been
recently reported that Mn2+ is able to induce apoptotic cell death
through a caspase-dependent pathway [63]. The same authors demon-
strated that Yca1p is not involved in copper-induced apoptosis, indi-
cating that the activation of caspase is not common to all metal ions.
6. Yeast mutants undergoing apoptosis in a
YCA1-dependent manner
Yeast apoptosis was ﬁrst described in cells carrying a mutated
CDC48 gene, which codes for the AAA-ATPase and has roles in cell
division, ubiquitin-dependent ER-associated protein degradation
(ERAD) and vesicle trafﬁcking [64]. Later on, it was found that
mutations in the VCP, the metazoan homolog of the yeast CDC48, gave
rise to apoptotic phenotypes in mammalian cell cultures [65,66], in
trypanosomes [67], in Drosophila [68] and in zebraﬁsh [69]. These
ﬁndings corroborated the establishment of yeast as a model to study
evolutionary conserved mechanisms of apoptotic regulation [3,70,71].
It has been recently reported that an increased caspase activity can
be detected just in cdc48S565G mutant cells, suggesting that YCA1 is
activated in this mutant [72].
During the last years, other mutants showing apoptotic pheno-
types were described and, for many of them, it was demonstrated an
involvement of the metacaspase YCA1 as the executor of the mutant-
induced cell death.
YCA1 activation seems to be also related to defects in numerous
cellular fundamental processes such as DNA replication, mitochon-
drial function, RNA and protein stability.
6.1. DNA replication
The origin recognition complex (ORC) is a six-subunit complex
of proteins required for initiation of DNA duplication at replication
origins in all eukaryotes [73].
Cdc6p, a component of the pre-replicative complex required for
the initiation of eukaryotic DNA replication, is rapidly degraded in a
proteasome-dependent way in cells undergoing apoptosis induced by
the DNA-damaging drug adozelesin, and such mechanism is con-
served from human to yeast [74].ORC2 codes for a subunit of the ORC and orc2-1 ts mutant cells, at
non-permissive temperature, show defects in initiation of DNA repli-
cation, activate DNA damage responses and undergo apoptosis [75].
Apoptosis in orc2-1 cells includes the production of reactive
oxygen species (ROS) and the activation of Yca1p, which contributes to
the lethality of the orc2-1mutation. Both ROS and activation of Yca1p
are likely induced by DNA damage associated with the collapse of DNA
replication forks in cells with defective checkpoints and incompletely
replicated chromosomes [75].
6.2. mRNA stability
The turn over rate of speciﬁc mRNAs can be an important factor to
the overall expression levels of proteins, and perturbation on this
process could have a large impact on changes in gene expression. In
yeast, mRNA turnover follows at least three decay pathways [76].
In two of these, 5′/3′ exonucleolytic digestion of mRNAs follows a
decapping event, whereas in the third pathway, transcripts are de-
graded by 3′/5′ exonucleolytic digestion. In the decapping-dependent
pathway, mRNAs are degraded in speciﬁc cytoplasmic foci, called P-
bodies, the number and size of which vary during growth and after
cellular stress [77]. It has been reported that mutants in P-bodies
components (dcp1, dcp2, dhh1, lsm1-7) show apoptotic phenotypes
and accelerated chronological aging [78]. At least in one of these
mutants (Kllsm4Δ1), apoptotic death was dependent on the presence
of the metacaspase activity coded by YCA1 gene. In fact, the double
mutant lsm4Δ1/yca1Δ showed a reduced percentage of cells with
apoptotic phenotypes and increased viability during chronological
aging [60].
6.3. Protein stability
Post-translational modiﬁcation of proteins by covalent attachment
of ubiquitin (Ub) is one of the major biochemical mechanisms that
regulate the cell death program [79]. Some experimental evidences
suggest a connection between ubiquitination and apoptosis also in
yeast. In fact, Cdc48p is required for endoplasmic reticulum-asso-
ciated protein degradation by the proteasome [80] and the accumula-
tion of Stm1p, a proteasomal substrate, speciﬁcally induces cell death,
while cells lacking Stm1p display a higher survival after hydrogen
peroxide-induced apoptosis [81].
The loss of UBP10, which codes for a deubiquitinating enzyme,
leads to premature cell death that can be efﬁciently rescued by the
deletion of YCA1 [82].
7. Expression of heterologous apoptotic proteins
The heterologous expression of mammalian apoptotic proteins in
yeast has been shown to induce some features of apoptosis, sug-
gesting the presence of a conserved basal cell death program in this
unicellular organism.
In previous studies in yeast, only the over-expression of caspase 8
led to cell death while the over-expression of caspase 3 was not lethal
and only retarded yeast growth [83,84].
More recently it has been reported that the expression of active
metazoan caspases (human, Drosophila and C. elegans) disrupts the
plasma and nuclear membranes of S. cerevisiae leading to the loss of
clonogenic potential, without damaging DNA.
The toxicity of heterologous caspases does not require the yeast
apoptotic regulators Yca1p and Aif1p [85].
Moreover, loss of YCA1 or AIF1 did not result in protection from the
toxicity induced by the pro-apoptotic protein Bax [86,87], suggesting
that, in this case, cell death probably occurred through autophagy.
Metacaspases from other organism, including plants and proto-
zoan parasites, have been expressed in yeast and some of them could
complement the absence of YCA1.
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AtMCP2b) expressed in yca1 mutant cells were demonstrated to be
involved in apoptosis induced by oxidative stress and during senescence
[88]. The expression of the single metacaspase gene from the parasite
Leishmania major in the YCA1 null mutant was able to restore the
sensitivity of yeast cells to oxidative stress with survival levels and
apoptotic features similar to those of mutant cells complemented
with YCA1, suggesting a similar functional role of these metacaspases in
yeast [89].
Yeast is also a useful model to study the age-related degeneration
of post-mitotic cells such as neuronal pathologies [90].
The neuronal protein alpha-synuclein (alpha-syn) has been
suggested to be one of the factors linked to Parkinson's disease (PD).
Yeast cells expressing alpha-syn accumulate lipid droplets, show
vacuolar/lysosomal defects and exhibit apoptotic markers, including
the externalization of phosphatidylserine, the release of cytochrome c,
and the accumulation of reactive oxygen species. Deletion of the YCA1
gene abolishes the ability of alpha-syn to induce ROS accumulation
and promotes vigorous growth of alpha-syn-expressing cells. These
ﬁndings indicate that alpha-syn-induced ROS generation is mediated
by the caspase and suggest that the expression of alpha-syn activates
the caspase activity that, in turn, stimulates the production of ROS and
triggers apoptosis [91]. Very recently, another paper that contradicts
the notion that YCA1 is needed for alpha-synuclein toxicity [92].
Huntington's disease is caused by speciﬁc mutations in huntingtin
protein. Expansion of a polyglutamine (polyQ) repeat of huntingtin
leads to protein aggregation in neurons followed by cell death with
apoptotic markers. In yeast, similar to neurons, expanded polyQ ag-
gregates accumulate in the nucleus and induce mitochondrial frag-
mentation, caspase activation and cell death. Although the absence of
Yca1p did not rescue signiﬁcantly the detrimental effect of 103Q on
the colony growth, the intracellular localization of the aggregates was
strongly affected, with a four times lower nuclear localization in the
deletion mutant compared to wild type [93].Fig. 1. Caspase-dependent pat8. Proteins that interact with Yca1
Comprehensive two-hybrid screens revealed interactions of the
yeast caspase with several proteins [94–97].
WWM1 (YFL010c) encodes a protein of 211 amino acids character-
ized by a high glycine content (14%) and high hydrophilicity. It was
categorized as a potential hydrophilin, a class of proteins that are often
involved in osmotic stress response [98].Wwm1p contains a 40 amino
acid N-terminal domainwith two signature tryptophan residues (WW
domain), a widespread module mediating protein–protein interac-
tions in a variety of cellular processes [99]. The over-expression of
WWM1 in wild type yeast caused severe growth retardation and loss
of clonogenicity. The contemporary over-expression of WWM1 and
YCA1 resulted in suppression of this phenotype while the inactivation
of YCA1 did not prevent the WWM1 toxicity [13].
SRO77 (YBL106c) codes for a protein homolog to Sro7p and to the
Drosophila lethal giant larvae (lgl) tumor suppressor [100] that have
roles in exocytosis and cation homeostasis [101]. Moreover, Sro7p
functions in docking and fusion of post-Golgi vesicles with plasma
membrane and mutants lacking this protein show high sensitivity to
NaCl stress and apoptotic phenotypes. Although the deletion of YCA1
increases the resistance of wild type cells to hyperosmotic stress, the
double mutant yca1/sro77 shows the same sensitivity as the wild type.
Moreover, in the sro77mutant, the caspase activity is not enhanced after
NaCl stress suggesting that Sro77p is required for salt induced activation
of Yca1p. Unexpectedly Sro7p, the Sro77p homolog, has an opposite
effect in that it seems to moderate the activity of the caspase [52].
Three proteins encoded by other genes have been reported to
interact with Yca1p but, up to now, no functional connection has been
established.
PIN3 (YPR154w) codes for a protein that induces the appearance of
[PIN+] prion when overproduced [102].
SDC25 (YLL017w) codes for a non-essential Ras guanine nucleotide
exchange factor (GEF) homologous to CDC25 [103,104].hways of yeast apoptosis.
Table 1
Yca1p-dependent yeast cell death












orc2-1 DNA replication [75]
lsm4Δ1 Decapping [60]
ﬁs1Δ Mitochondrial ﬁssion [37]
cit1 Mitochondrial metabolism [38]
isc1 Mitochondrial metabolism [39]
Expression of proteins involved in human diseases
Expanded polyQ domain expression Huntington's disease,
neurodegeneration
[93]






1325C. Mazzoni, C. Falcone / Biochimica et Biophysica Acta 1783 (2008) 1320–1327Recently, by afﬁnity capture-MS another Yca1p interacting protein
has been identiﬁed, encoded by ARC1 (YGL105w) [105]. This protein
binds tRNAs and delivers them to methionyl- and glutamyl-tRNA
synthetases.
9. Concluding remarks
On the basis of the reported cases, YCA1 seems to be the executor
for a wide range of apoptotic stimuli, both external and internal (Fig. 1
and Table 1). Inmost of these cases, a role ofmitochondria in cell death
has been described, linking the function of this organelle to the YCA1-
mediated cell death, as described for the metazoan intrinsic apoptotic
pathway [34,106]. Bacterial extracts containing recombinant Yca1p
exhibited arginine/lysine speciﬁc cysteine endopeptidase activity,
which was not inhibited by the inhibitor of caspase z-VAD-fmk [88].
This result might suggest that Yca1p exhibits a site speciﬁcity different
from that of metazoan caspases, although artifacts linked to the
properties of the recombinant protein cannot be excluded.
Moreover, it is likely that the yeast genome contains, besides
Yca1p, other metacaspases which might not cleave the ﬂuorogenic
caspase substrates commonly used, pointing to the existence of other
cell death executors still to be characterized.
A crucial aspect that requires a deeper investigation concerns the
identiﬁcation of the physiological substrates of the yeast metacaspase.
Such information will allow a great advance in the understanding the
apoptotic pathways in yeast and the similarities with those operating
in higher eukaryotes.
References
[1] G. Kroemer, W.S. El-Deiry, P. Golstein, M.E. Peter, D. Vaux, P. Vandenabeele, B.
Zhivotovsky, M.V. Blagosklonny, W. Malorni, R.A. Knight, M. Piacentini, S. Nagata,
G. Melino, Classiﬁcation of cell death: recommendations of the Nomenclature
Committee on Cell Death, Cell Death Differ. 12 (Suppl 2) (2005) 1463–1467.
[2] M. Ligr, F. Madeo, E. Frohlich, W. Hilt, K.U. Frohlich, D.H. Wolf, Mammalian Bax
triggers apoptotic changes in yeast, FEBS Lett. 438 (1998) 61–65.
[3] K.U. Frohlich, H. Fussi, C. Ruckenstuhl, Yeast apoptosis—from genes to pathways,
Semin. Cancer Biol. 17 (2007) 112–121.
[4] F. Madeo, E. Herker, C. Maldener, S. Wissing, S. Lachelt, M. Herlan, M. Fehr, K.
Lauber, S.J. Sigrist, S. Wesselborg, K.U. Frohlich, A caspase-related protease
regulates apoptosis in yeast, Mol. Cell 9 (2002) 911–917.[5] B. Fahrenkrog, U. Sauder, U. Aebi, The S. cerevisiae HtrA-like protein Nma111p is a
nuclear serine protease that mediates yeast apoptosis, J. Cell Sci. 117 (2004)
115–126.
[6] S. Wissing, P. Ludovico, E. Herker, S. Buttner, S.M. Engelhardt, T. Decker, A. Link, A.
Proksch, F. Rodrigues, M. Corte-Real, K.U. Frohlich, J. Manns, C. Cande, S.J. Sigrist,
G. Kroemer, F. Madeo, An AIF orthologue regulates apoptosis in yeast, J. Cell Biol.
166 (2004) 969–974.
[7] S. Buttner, T. Eisenberg, D. Carmona-Gutierrez, D. Ruli, H. Knauer, C. Ruckenstuhl,
C. Sigrist, S. Wissing, M. Kollroser, K.U. Frohlich, S. Sigrist, F. Madeo, Endonuclease
G regulates budding yeast life and death, Mol. Cell 25 (2007) 233–246.
[8] J.C. Timmer, G.S. Salvesen, Caspase substrates, Cell Death Differ. 14 (2007) 66–72.
[9] M. Donepudi, M.G. Grutter, Structure and zymogen activation of caspases,
Biophys. Chemist. 101–102 (2002) 145–153.
[10] A.Degterev,M. Boyce, J. Yuan,Adecadeof caspases, Oncogene22 (2003) 8543–8567.
[11] I.N. Lavrik, A. Golks, P.H. Krammer, Caspases: pharmacological manipulation of
cell death, J. Clin. Invest. 115 (2005) 2665–2672.
[12] A.G. Uren, K. O'Rourke, L.A. Aravind, M.T. Pisabarro, S. Seshagiri, E.V. Koonin, V.M.
Dixit, Identiﬁcation of paracaspases and metacaspases: two ancient families of
caspase-like proteins, one of which plays a key role in MALT lymphoma, Mol. Cell
6 (2000) 961–967.
[13] A. Szallies, B.K. Kubata, M. Duszenko, A metacaspase of Trypanosoma brucei
causes loss of respiration competence and clonal death in the yeast Saccharo-
myces cerevisiae, FEBS Lett. 517 (2002) 144–150.
[14] M. Bras, B. Queenan, S.A. Susin, Programmed cell death via mitochondria:
different modes of dying, Biochemistry (Mosc.) 70 (2005) 231–239.
[15] M. Crompton, The mitochondrial permeability transition pore and its role in cell
death, Biochem. J. 341 (Pt 2) (1999) 233–249.
[16] J.C. Martinou, S. Desagher, B. Antonsson, Cytochrome c release from mitochon-
dria: all or nothing, Nat. Cell Biol. 2 (2000) E41–E43.
[17] D. Walter, S. Wissing, F. Madeo, B. Fahrenkrog, The inhibitor-of-apoptosis protein
Bir1p protects against apoptosis in S. cerevisiae and is a substrate for the yeast
homologue of Omi/HtrA2, J. Cell Sci. 119 (2006) 1843–1851.
[18] S. Manon, B. Chaudhuri, M. Guerin, Release of cytochrome c and decrease of
cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these
effects by coexpression of Bcl-xL, FEBS Lett. 415 (1997) 29–32.
[19] K. Li, Y. Li, J.M. Shelton, J.A. Richardson, E. Spencer, Z.J. Chen, X. Wang, R.S.
Williams, Cytochrome c deﬁciency causes embryonic lethality and attenuates
stress-induced apoptosis, Cell 101 (2000) 389–399.
[20] A. Gross, K. Pilcher, E. Blachly-Dyson, E. Basso, J. Jockel, M.C. Bassik, S.J. Korsmeyer,
M. Forte, Biochemical and genetic analysis of the mitochondrial response of yeast
to BAX and BCL-X(L), Mol. Cell. Biol. 20 (2000) 3125–3136.
[21] A.I. Pozniakovsky, D.A. Knorre, O.V. Markova, A.A. Hyman, V.P. Skulachev, F.F.
Severin, Role of mitochondria in the pheromone- and amiodarone-induced
programmed death of yeast, J. Cell Biol. 168 (2005) 257–269.
[22] M. Priault, B. Chaudhuri, A. Clow, N. Camougrand, S. Manon, Investigation of bax-
induced release of cytochrome c from yeast mitochondria permeability of
mitochondrial membranes, role of VDAC and ATP requirement, Eur. J. Biochem.
260 (1999) 684–691.
[23] R.D. Silva, R. Sotoca, B. Johansson, P. Ludovico, F. Sansonetty, M.T. Silva, J.M. Peinado,
M. Corte-Real, Hyperosmotic stress induces metacaspase- and mitochondria-
dependent apoptosis in Saccharomyces cerevisiae,Mol.Microbiol. 58 (2005) 824–834.
[24] X. Roucou, M. Prescott, R.J. Devenish, P. Nagley, A cytochrome c–GFP fusion is not
released from mitochondria into the cytoplasm upon expression of Bax in yeast
cells, FEBS Lett. 471 (2000) 235–239.
[25] I. Kissova, P. Polcic, P. Kempna, I. Zeman, L. Sabova, J. Kolarov, The cytotoxic action
of Bax on yeast cells does not require mitochondrial ADP/ATP carrier but may be
related to its import to the mitochondria, FEBS Lett. 471 (2000) 113–118.
[26] I. Marzo, C. Brenner, N. Zamzami, J.M. Jurgensmeier, S.A. Susin, H.L. Vieira, M.C.
Prevost, Z. Xie, S. Matsuyama, J.C. Reed, G. Kroemer, Bax and adenine nucleotide
translocator cooperate in the mitochondrial control of apoptosis, Science 281
(1998) 2027–2031.
[27] M. Priault, N. Camougrand, B. Chaudhuri, J. Schaeffer, S. Manon, Comparison of
the effects of bax-expression in yeast under fermentative and respiratory
conditions: investigation of the role of adenine nucleotides carrier and
cytochrome c, FEBS Lett. 456 (1999) 232–238.
[28] S. Shimizu, M. Narita, Y. Tsujimoto, Bcl-2 family proteins regulate the release of
apoptogenic cytochrome c by the mitochondrial channel VDAC, Nature 399
(1999) 483–487.
[29] C. Pereira, N. Camougrand, S. Manon, M.J. Sousa, M. Corte-Real, ADP/ATP carrier is
required for mitochondrial outer membrane permeabilization and cytochrome c
release in yeast apoptosis, Mol. Microbiol. 66 (2007) 571–582.
[30] T. Nakagawa, S. Shimizu, T. Watanabe, O. Yamaguchi, K. Otsu, H. Yamagata, H.
Inohara, T. Kubo, Y. Tsujimoto, Cyclophilin D-dependent mitochondrial perme-
ability transition regulates some necrotic but not apoptotic cell death, Nature 434
(2005) 652–658.
[31] G.W. Thorpe, C.S. Fong, N. Alic, V.J. Higgins, I.W. Dawes, Cells have distinct
mechanisms to maintain protection against different reactive oxygen species:
oxidative-stress-response genes, Proc. Natl. Acad. Sci. U. S. A.101 (2004) 6564–6569.
[32] P. Schafer, S.R. Scholz, O. Gimadutdinow, I.A. Cymerman, J.M. Bujnicki, A. Ruiz-
Carrillo, A. Pingoud, G. Meiss, Structural and functional characterization of
mitochondrial EndoG, a sugar non-speciﬁc nuclease which plays an important
role during apoptosis, J. Mol. Biol. 338 (2004) 217–228.
[33] S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J.
Mangion, E. Jacotot, P. Costantini, M. Loefﬂer, N. Larochette, D.R. Goodlett, R.
Aebersold, D.P. Siderovski, J.M. Penninger, G. Kroemer, Molecular characterization
of mitochondrial apoptosis-inducing factor, Nature 397 (1999) 441–446.
1326 C. Mazzoni, C. Falcone / Biochimica et Biophysica Acta 1783 (2008) 1320–1327[34] T. Eisenberg, S. Buttner, G. Kroemer, F. Madeo, The mitochondrial pathway in
yeast apoptosis, Apoptosis 12 (2007) 1011–1023.
[35] G.M. Cereghetti, L. Scorrano, The many shapes of mitochondrial death, Oncogene
25 (2006) 4717–4724.
[36] K.L. Cerveny, Y. Tamura, Z. Zhang, R.E. Jensen, H. Sesaki, Regulation of
mitochondrial fusion and division, Trends Cell Biol. 17 (2007) 563–569.
[37] Y. Fannjiang, W.C. Cheng, S.J. Lee, B. Qi, J. Pevsner, J.M. McCaffery, R.B. Hill, G.
Basanez, J.M. Hardwick, Mitochondrial ﬁssion proteins regulate programmed cell
death in yeast, Genes Dev. 18 (2004) 2785–2797.
[38] Y.J. Lee, K.L. Hoe, P.J. Maeng, Yeast cells lacking the CIT1-encoded mitochondrial
citrate synthase are hypersusceptible to heat- or aging-induced apoptosis, Mol.
Biol. Cell 18 (2007) 3556–3567.
[39] T. Almeida,M.Marques,D.Mojzita,M.A. Amorim, R.D. Silva, B. Almeida, P. Rodrigues,
P. Ludovico, S. Hohmann, P. Moradas-Ferreira, M. Corte-Real, V. Costa, Isc1p plays a
key role in hydrogen peroxide resistance and chronological lifespan through
modulation of iron levels and apoptosis, Mol. Biol. Cell 19 (2008) 865–876.
[40] F.F. Severin, A.A. Hyman, Pheromone induces programmed cell death in S.
cerevisiae, Curr. Biol. 12 (2002) R233–R235.
[41] E. Herker, H. Jungwirth, K.A. Lehmann, C. Maldener, K.U. Frohlich, S. Wissing, S.
Buttner, M. Fehr, S. Sigrist, F. Madeo, Chronological aging leads to apoptosis in
yeast, J. Cell Biol. 164 (2004) 501–507.
[42] I. Ivanovska, J.M. Hardwick, Viruses activate a genetically conserved cell death
pathway in a unicellular organism, J. Cell Biol. 170 (2005) 391–399.
[43] J. Reiter, E. Herker, F. Madeo, M.J. Schmitt, Viral killer toxins induce caspase-
mediated apoptosis in yeast, J. Cell Biol. 168 (2005) 353–358.
[44] L. Vachova, Z. Palkova, Physiological regulation of yeast cell death in multicellular
colonies is triggered by ammonia, J. Cell Biol. 169 (2005) 711–717.
[45] M.J. Schmitt, F. Breinig, Yeast viral killer toxins: lethality and self-protection, Nat.
Rev. Microbiol. 4 (2006) 212–221.
[46] F. Madeo, E. Frohlich, M. Ligr, M. Grey, S.J. Sigrist, D.H. Wolf, K.U. Frohlich, Oxygen
stress: a regulator of apoptosis in yeast, J. Cell Biol. 145 (1999) 757–767.
[47] P. Ludovico, M.J. Sousa, M.T. Silva, C. Leao, M. Corte-Real, Saccharomyces cerevisiae
commits to a programmed cell death process in response to acetic acid,
Microbiology 147 (2001) 2409–2415.
[48] L. Saraiva, R.D. Silva, G. Pereira, J. Goncalves, M. Corte-Real, Speciﬁc modulation of
apoptosis and Bcl-xL phosphorylation in yeast by distinct mammalian protein
kinase C isoforms, J. Cell Sci. 119 (2006) 3171–3181.
[49] N. Guaragnella, C. Pereira, M.J. Sousa, L. Antonacci, S. Passarella, M. Corte-Real, E.
Marra, S. Giannattasio, YCA1 participates in the acetic acid induced yeast
programmed cell death also in a manner unrelated to its caspase-like activity,
FEBS Lett. 580 (2006) 6880–6884.
[50] A.R. Wright, S.A. Rees, Cardiac cell volume: crystal clear or murky waters? A
comparison with other cell types, Pharmacol. Ther. 80 (1998) 89–121.
[51] A. Galvez, M.P. Morales, J.M. Eltit, P. Ocaranza, L. Carrasco, X. Campos, M. Sapag-
Hagar, G. Diaz-Araya, S. Lavandero, A rapid and strong apoptotic process is
triggered by hyperosmotic stress in cultured rat cardiac myocytes, Cell Tissue Res.
304 (2001) 279–285.
[52] I. Wadskog, C. Maldener, A. Proksch, F. Madeo, L. Adler, Yeast lacking the SRO7/
SOP1-encoded tumor suppressor homologue show increased susceptibility to
apoptosis-like cell death on exposure to NaCl stress, Mol. Biol. Cell 15 (2004)
1436–1444.
[53] R.A. Blaheta, H. Nau, M. Michaelis, J. Cinatl Jr., Valproate and valproate-analogues:
potent tools to ﬁght against cancer, Curr. Med. Chem. 9 (2002) 1417–1433.
[54] V. Medina, B. Edmonds, G.P. Young, R. James, S. Appleton, P.D. Zalewski, Induction
of caspase-3 protease activity and apoptosis by butyrate and trichostatin A
(inhibitors of histone deacetylase): dependence on protein synthesis and synergy
with a mitochondrial/cytochrome c-dependent pathway, Cancer Res. 57 (1997)
3697–3707.
[55] P. Finzer, C. Kuntzen, U. Soto, H. zur Hausen, F. Rosl, Inhibitors of histone deacetylase
arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing
human papillomavirus oncogene expression, Oncogene 20 (2001) 4768–4776.
[56] R. Kawagoe, H. Kawagoe, K. Sano, Valproic acid induces apoptosis in human
leukemia cells by stimulating both caspase-dependent and -independent
apoptotic signaling pathways, Leuk. Res. 26 (2002) 495–502.
[57] K. Mitsui, D. Nakagawa, M. Nakamura, T. Okamoto, K. Tsurugi, Valproic acid
induces apoptosis dependent of Yca1p at concentrations that mildly affect the
proliferation of yeast, FEBS Lett. 579 (2005) 723–727.
[58] L. Du, Y. Yu, J. Chen, Y. Liu, Y. Xia, Q. Chen, X. Liu, Arsenic induces caspase- and
mitochondria-mediated apoptosis in Saccharomyces cerevisiae, FEMS Yeast Res.
7 (2007) 860–865.
[59] Z. He, W.Y. Ma, T. Hashimoto, A.M. Bode, C.S. Yang, Z. Dong, Induction of apoptosis
by caffeine is mediated by the p53, Bax, and caspase 3 pathways, Cancer Res.
63 (2003) 4396–4401.
[60] C. Mazzoni, E. Herker, V. Palermo, H. Jungwirth, T. Eisenberg, F. Madeo, C. Falcone,
Yeast caspase 1 links messenger RNA stability to apoptosis in yeast, EMBO Rep.
6 (2005) 1076–1081.
[61] P.K. Pal, A. Samii, D.B. Calne, Manganese neurotoxicity: a review of clinical
features, imaging and pathology, Neurotoxicology 20 (1999) 227–238.
[62] J. Kaiser, Manganese: a high-octane dispute, Science 300 (2003) 926–928.
[63] Q. Liang, B. Zhou, Copper and manganese induce yeast apoptosis via different
pathways, Mol. Biol. Cell 18 (2007) 4741–4749.
[64] F. Madeo, E. Frohlich, K.U. Frohlich, A yeast mutant showing diagnostic markers of
early and late apoptosis, J. Cell Biol. 139 (1997) 729–734.
[65] T. Shirogane, T. Fukada, J.M.Muller, D.T. Shima, M. Hibi, T. Hirano, Synergistic roles
for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis,
Immunity 11 (1999) 709–719.[66] M. Hirabayashi, K. Inoue, K. Tanaka, K. Nakadate, Y. Ohsawa, Y. Kamei, A.H. Popiel,
A. Sinohara, A. Iwamatsu, Y. Kimura, Y. Uchiyama, S. Hori, A. Kakizuka, VCP/p97 in
abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes
relevant to neurodegeneration, Cell Death Differ. 8 (2001) 977–984.
[67] J.R. Lamb, V. Fu, E. Wirtz, J.D. Bangs, Functional analysis of the trypanosomal AAA
protein TbVCP with trans-dominant ATP hydrolysis mutants, J. Biol. Chem.
276 (2001) 21512–21520.
[68] H. Higashiyama, F. Hirose, M. Yamaguchi, Y.H. Inoue, N. Fujikake, A. Matsukage, A.
Kakizuka, Identiﬁcation of ter94, Drosophila VCP, as a modulator of polygluta-
mine-induced neurodegeneration, Cell Death Differ. 9 (2002) 264–273.
[69] S. Imamura, N. Ojima, M. Yamashita, Cold-inducible expression of the cell division
cycle gene CDC48 and its promotion of cell proliferation during cold acclimation
in zebraﬁsh cells, FEBS Lett. 549 (2003) 14–20.
[70] F. Madeo, E. Herker, S. Wissing, H. Jungwirth, T. Eisenberg, K.U. Frohlich,
Apoptosis in yeast, Curr. Opin. Microbiol. 7 (2004) 655–660.
[71] C.W. Gourlay, W. Du, K.R. Ayscough, Apoptosis in yeast-mechanisms and beneﬁts
to a unicellular organism, Mol. Microbiol. 62 (2006) 1515–1521.
[72] R.J. Braun, H. Zischka, F. Madeo, T. Eisenberg, S. Wissing, S. Buttner, S.M.
Engelhardt, D. Buringer, M. Uefﬁng, Crucial mitochondrial impairment upon
CDC48 mutation in apoptotic yeast, J. Biol. Chem. 281 (2006) 25757–25767.
[73] J.F. Difﬂey, DNA replication: building the perfect switch, Curr. Biol. 11 (2001)
R367–R370.
[74] F. Blanchard, M.E. Rusiniak, K. Sharma, X. Sun, I. Todorov, M.M. Castellano, C.
Gutierrez, H. Baumann, W.C. Burhans, Targeted destruction of DNA replication
protein Cdc6 by cell death pathways in mammals and yeast, Mol. Biol. Cell 13
(2002) 1536–1549.
[75] M. Weinberger, L. Ramachandran, L. Feng, K. Sharma, X. Sun, M. Marchetti, J.A.
Huberman, W.C. Burhans, Apoptosis in budding yeast caused by defects in
initiation of DNA replication, J. Cell Sci. 118 (2005) 3543–3553.
[76] S.R. Kushner, mRNA decay in prokaryotes and eukaryotes: different approaches to
a similar problem, IUBMB Life 56 (2004) 585–594.
[77] D. Teixeira, U. Sheth, M.A. Valencia-Sanchez, M. Brengues, R. Parker, Processing
bodies require RNA for assembly and contain nontranslating mRNAs, RNA
11 (2005) 371–382.
[78] C. Mazzoni, P. Mancini, L. Verdone, F. Madeo, A. Seraﬁni, E. Herker, C. Falcone, A
truncated form of KlLsm4p and the absence of factors involved in mRNA
decapping trigger apoptosis in yeast, Mol. Biol. Cell 14 (2003) 721–729.
[79] J.C. Lee, M.E. Peter, Regulation of apoptosis by ubiquitination, Immunol. Rev.
193 (2003) 39–47.
[80] E. Jarosch, C. Taxis, C. Volkwein, J. Bordallo, D. Finley, D.H. Wolf, T. Sommer,
Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase
Cdc48, Nat. Cell Biol. 4 (2002) 134–139.
[81] M. Ligr, I. Velten, E. Frohlich, F. Madeo, M. Ledig, K.U. Frohlich, D.H. Wolf, W. Hilt,
The proteasomal substrate Stm1 participates in apoptosis-like cell death in yeast,
Mol. Biol. Cell 12 (2001) 2422–2432.
[82] M. Bettiga, L. Calzari, I. Orlandi, L. Alberghina, M. Vai, Involvement of the
yeast metacaspase Yca1 in ubp10Delta-programmed cell death, FEMS Yeast Res.
5 (2004) 141–147.
[83] J.J. Kang, M.D. Schaber, S.M. Srinivasula, E.S. Alnemri, G. Litwack, D.J. Hall, M.A.
Bjornsti, Cascades of mammalian caspase activation in the yeast Saccharomyces
cerevisiae, J. Biol. Chem. 274 (1999) 3189–3198.
[84] M.E. Wright, D.K. Han, L. Carter, S. Fields, S.M. Schwartz, D.M. Hockenbery,
Caspase-3 inhibits growth in Saccharomyces cerevisiae without causing cell
death, FEBS Lett. 446 (1999) 9–14.
[85] M.A. Puryer, C.J. Hawkins, Human, insect and nematode caspases kill Saccharo-
myces cerevisiae independently of YCA1 and Aif1p, Apoptosis 11 (2006) 509–517.
[86] F. Guscetti, N. Nath, N. Denko, Functional characterization of human proapoptotic
molecules in yeast S. cerevisiae, FASEB J. 19 (2005) 464–466.
[87] I. Kissova, L.T. Plamondon, L. Brisson, M. Priault, V. Renouf, J. Schaeffer, N.
Camougrand, S. Manon, Evaluation of the roles of apoptosis, autophagy, and
mitophagy in the loss of plating efﬁciency induced by Bax expression in yeast,
J. Biol. Chem. 281 (2006) 36187–36197.
[88] N. Watanabe, E. Lam, Two Arabidopsis metacaspases AtMCP1b and AtMCP2b are
arginine/lysine-speciﬁc cysteine proteases and activate apoptosis-like cell death
in yeast, J. Biol. Chem. 280 (2005) 14691–14699.
[89] I.J. Gonzalez, C. Desponds, C. Schaff, J.C. Mottram, N. Fasel, Leishmania major
metacaspase can replace yeast metacaspase in programmed cell death and has
arginine-speciﬁc cysteine peptidase activity, Int. J. Parasitol. 37 (2007) 161–172.
[90] Q. Chen, Q. Ding, J.N. Keller, The stationary phase model of aging in yeast for the
study of oxidative stress and age-related neurodegeneration, Biogerontology
6 (2005) 1–13.
[91] T.R. Flower, L.S. Chesnokova, C.A. Froelich, C. Dixon, S.N.Witt, Heat shock prevents
alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease, J. Mol.
Biol. 351 (2005) 1081–1100.
[92] S. Buttner, A. Bitto, J. Ring, M. Augsten, P. Zabrocki, T. Eisenberg, H. Jungwirth, S.
Hutter, D. Carmona-Gutierrez, G. Kroemer, J. Winderickx, F. Madeo, Functional
mitochondria are required for alpha-synuclein toxicity in ageing yeast, J. Biol.
Chem. 283 (2008) 7554–7560.
[93] S. Sokolov, A. Pozniakovsky, N. Bocharova, D. Knorre, F. Severin, Expression of an
expanded polyglutamine domain in yeast causes death with apoptotic markers,
Biochim. Biophys. Acta 1757 (2006) 660–666.
[94] P. Uetz, L. Giot, G. Cagney, T.A. Mansﬁeld, R.S. Judson, J.R. Knight, D. Lockshon, V.
Narayan, M. Srinivasan, P. Pochart, A. Qureshi-Emili, Y. Li, B. Godwin, D. Conover,
T. Kalbﬂeisch, G. Vijayadamodar, M. Yang, M. Johnston, S. Fields, J.M. Rothberg, A
comprehensive analysis of protein–protein interactions in Saccharomyces
cerevisiae, Nature 403 (2000) 623–627.
1327C. Mazzoni, C. Falcone / Biochimica et Biophysica Acta 1783 (2008) 1320–1327[95] B.L. Drees, B. Sundin, E. Brazeau, J.P. Caviston, G.C. Chen, W. Guo, K.G. Kozminski,
M.W. Lau, J.J. Moskow, A. Tong, L.R. Schenkman, A. McKenzie III, P. Brennwald, M.
Longtine, E. Bi, C. Chan, P. Novick, C. Boone, J.R. Pringle, T.N. Davis, S. Fields, D.G.
Drubin, A protein interaction map for cell polarity development, J. Cell Biol.
154 (2001) 549–571.
[96] T. Ito, T. Chiba, R. Ozawa, M. Yoshida, M. Hattori, Y. Sakaki, A comprehensive two-
hybrid analysis to explore the yeast protein interactome, Proc. Natl. Acad. Sci.
U. S. A. 98 (2001) 4569–4574.
[97] A.H. Tong, B. Drees, G. Nardelli, G.D. Bader, B. Brannetti, L. Castagnoli, M.
Evangelista, S. Ferracuti, B. Nelson, S. Paoluzi, M. Quondam, A. Zucconi, C.W.
Hogue, S. Fields, C. Boone, G. Cesareni, A combined experimental and
computational strategy to deﬁne protein interaction networks for peptide
recognition modules, Science 295 (2002) 321–324.
[98] A. Garay-Arroyo, J.M. Colmenero-Flores, A. Garciarrubio, A.A. Covarrubias, Highly
hydrophilic proteins in prokaryotes and eukaryotes are common during
conditions of water deﬁcit, J. Biol. Chem. 275 (2000) 5668–5674.
[99] M. Sudol, K. Sliwa, T. Russo, Functions of WW domains in the nucleus, FEBS Lett.
490 (2001) 190–195.
[100] K. Larsson, F. Bohl, I. Sjostrom, N. Akhtar, D. Strand, B.M. Mechler, R. Grabowski, L.
Adler, The Saccharomyces cerevisiae SOP1 and SOP2 genes, which act in cation
homeostasis, can be functionally substituted by the Drosophila lethal(2)giant
larvae tumor suppressor gene, J. Biol. Chem. 273 (1998) 33610–33618.[101] K. Lehman, G. Rossi, J.E. Adamo, P. Brennwald, Yeast homologues of tomosyn and
lethal giant larvae function in exocytosis and are associated with the plasma
membrane SNARE, Sec9, J. Cell Biol. 146 (1999) 125–140.
[102] I.L. Derkatch, M.E. Bradley, J.Y. Hong, S.W. Liebman, Prions affect the appearance
of other prions: the story of [PIN(+)], Cell 106 (2001) 171–182.
[103] F. Damak, E. Boy-Marcotte, D. Le-Roscouet, R. Guilbaud, M. Jacquet, SDC25, a
CDC25-like gene which contains a RAS-activating domain and is a dispensable
gene of Saccharomyces cerevisiae, Mol. Cell. Biol. 11 (1991) 202–212.
[104] E. Boy-Marcotte, P. Ikonomi, M. Jacquet, SDC25, a dispensable Ras guanine
nucleotide exchange factor of Saccharomyces cerevisiae differs from CDC25 by its
regulation, Mol. Biol. Cell 7 (1996) 529–539.
[105] N.J. Krogan, G. Cagney, H. Yu, G. Zhong, X. Guo, A. Ignatchenko, J. Li, S. Pu, N. Datta,
A.P. Tikuisis, T. Punna, J.M. Peregrin-Alvarez, M. Shales, X. Zhang, M. Davey, M.D.
Robinson, A. Paccanaro, J.E. Bray, A. Sheung, B. Beattie, D.P. Richards, V. Canadien,
A. Lalev, F. Mena, P. Wong, A. Starostine, M.M. Canete, J. Vlasblom, S. Wu, C. Orsi,
S.R. Collins, S. Chandran, R. Haw, J.J. Rilstone, K. Gandi, N.J. Thompson, G. Musso,
P. St Onge, S. Ghanny, M.H. Lam, G. Butland, A.M. Altaf-Ul, S. Kanaya, A.
Shilatifard, E. O'Shea, J.S. Weissman, C.J. Ingles, T.R. Hughes, J. Parkinson, M.
Gerstein, S.J. Wodak, A. Emili, J.F. Greenblatt, Global landscape of protein
complexes in the yeast Saccharomyces cerevisiae, Nature 440 (2006) 637–643.
[106] G. Kroemer, Mitochondrial control of apoptosis: an introduction, Biochem.
Biophys. Res. Commun. 304 (2003) 433–435.
